Lunch & Learn with Midas Pharma

In early-stage drug development, a well-defined analytical strategy can be the difference between momentum and missed opportunity.

Learn how advanced bioanalytical testing — ranging from glycan profiling to functional characterization of biologics — enables emerging biopharma companies to make confident, data-driven decisions.

This session will also provide practical insights from real-world case studies, illustrating how tailored analytics can accelerate development timelines and reduce risk.
Common challenges in regulatory strategy and development planning will also be addressed, with guidance on how to navigate them effectively.

Join us for a practical, insight-driven discussion designed to help early-stage innovators manage complexity, meet regulatory expectations, and move efficiently toward their next milestone.